Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 4 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Yesterday
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.

Adult height inversely associated with healthy ageing

22 Aug 2017

Taller adults are less likely to experience healthy ageing, according to a recent study. However, the association between height and ageing can be modified by a prudent diet rich in fruits and vegetables.

Researchers included 52,135 women (mean age 44.2 years) from the Nurses’ Health Study without chronic diseases in 1980 and whose health status was available in 2012 to examine the associations of adult height with healthy ageing measured by a full spectrum of health outcomes, such as incidence of chronic diseases, memory, physical functioning and mental health.

Healthy ageing referred to being free of 11 major chronic diseases and having no reported impairment of subjective memory, physical impairment or mental health limitations. Of the participants, 6,877 (13.2 percent) were classified as healthy agers.

There was an 8-percent (95 percent CI, 6 to 11 percent) reduction in the likelihood of healthy ageing per SD (0.062 m) increase in height after adjustment for demographic and lifestyle factors. The odds ratio of achieving healthy ageing in the highest category (≥1.70 m) was 0.80 (0.73 to 0.87; p<0.001) compared with the lowest category of height (≤1.57 m).

Furthermore, a significant relation existed between height and a prudent dietary pattern with regard to healthy ageing (p=0.005). Among the individual dietary factors distinguishing such diet, fruit and vegetable consumption showed the strongest effect modification (p=0.01).

“The association of greater height with reduced odds of healthy ageing appeared to be more evident among women with higher adherence to the prudent dietary pattern rich in vegetable and fruit intake,” researchers said.

“Adult height has shown directionally diverse associations with several age-related disorders, including cardiovascular disease, cancer, decline in cognitive function and mortality,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 4 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Yesterday
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.